Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Labour dystocia and oxytocin augmentation
Obstetrics and gynaecology · UK scope · Sources checked 7 Sept 2026 · Clinical review pending
!
Abnormal fetal heart or pain during augmentation
Excessive contractions, persistent fetal heart abnormalities, pain between contractions, bleeding or maternal instability during oxytocin require immediate reassessment. Increasing the infusion can worsen compromise when the problem is obstruction or uterine injury.
Action: Stop oxytocin for a pathological CTG and seek urgent obstetric review. Assess the fetal heart, maternal observations, contraction pattern and possible acute obstetric causes. Reposition, treat an identified reversible cause and prepare for urgent birth if compromise persists; suspected rupture or obstruction requires a definitive birth plan.
Overview
Assess slow labour using cervical change, fetal descent and the clinical picture, and use oxytocin only when augmentation is appropriate and safely monitored.
Dystocia describes difficult or abnormally slow progress, but the label should follow an assessment rather than replace one. Contractions may be ineffective, the fetal head may be malpositioned, or the relationship between the fetus and pelvis may prevent descent. Several factors can coexist. Fatigue, discomfort and an overfull bladder can also affect the experience and mechanics of labour. The first task is to establish whether labour is truly in the stage being assessed and whether the mother and baby remain well.
Augmentation increases uterine activity after labour has started, whereas induction initiates labour. Oxytocin can shorten the interval to birth when inadequate contractions contribute to delay, but it cannot correct every cause. Before prescribing it, consider presentation, position, pelvic findings, the fetal heart and any uterine scar. Explain expected benefits, stronger contractions, the need for CTG and the possibility that assisted or caesarean birth may still be needed. A shared decision should include the option to decline or pause treatment when clinically feasible.
Key points
Practice
Two practice questions
Your practice draft is saved in this browser.
Question 1 of 2
0 correct
Obstetrics and gynaecologyOriginal SBA
Confirming suspected delay
A nulliparous woman in established labour has progressed from 5 cm to 6 cm over four hours. Maternal and fetal findings are reassuring, and no immediate complication is identified. Which next assessment follows the NICE suspected-delay pathway?
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.
Slow labour is assessed from the whole pattern of dilatation, descent, rotation, contractions and maternal and fetal condition.
Do not diagnose established first-stage delay from a long latent phase alone.
Suspect first-stage delay with less than 2 cm progress in four hours in a first labour, or similarly slow or slowing progress in a subsequent labour.
When delay is suspected, offer a further examination two hours later; less than 1 cm progress confirms delay in the NICE pathway.
Amniotomy may help confirmed delay with intact membranes, followed by reassessment before considering oxytocin.
Oxytocin requires obstetric assessment, consent, continuous CTG and a prescription expressed clearly in milliunits per minute.
Titrate no more often than every thirty minutes towards three to four contractions in ten minutes, reducing stimulation if contractions become too frequent.
Aetiology
01
Ineffective uterine activity
Contractions may be too infrequent or insufficiently effective to produce progressive dilatation and descent. The diagnosis requires assessment of the whole clinical course before augmentation is considered.
02
Fetal position and pelvic relationships
Malposition, malpresentation or a difficult relationship between the presenting part and pelvis can hinder progress. Contraction strength alone cannot determine whether the mechanical conditions permit vaginal birth.
03
Maternal and treatment factors
Fatigue, bladder distension and analgesic effects may influence pushing or labour management. These contributors should be addressed without assuming that they explain every slow or abnormal course.
Pathophysiology
1
Inadequate effective force
When uterine activity does not generate sufficient coordinated pressure, cervical change or descent may slow. Oxytocin can increase activity, but its benefit depends on a suitable mechanical and fetal context.
2
Reduced placental recovery time
Frequent contractions shorten the intervals available for uteroplacental reperfusion. Excessive stimulation can therefore provoke fetal heart abnormalities even when increasing contraction frequency was intended to improve progress.
3
Obstructed descent
Failure of the presenting part to advance despite effective contractions may increase caput and moulding. Continued force against an unresolved obstruction can worsen maternal and fetal risk.
Clinical features and red flags
First-stage progress
Compare serial cervical examinations while considering parity, contraction strength and frequency, and fetal position. Less than 2 cm change over four hours is a reason to suspect delay in a first labour; slower progress in a subsequent labour also merits assessment. Do not apply this threshold to someone still in the latent phase.
The presenting part
Assess lie, presentation, engagement, station, position, caput and moulding. An occiput-posterior or transverse position may impair rotation and descent. Marked caput can make the head seem lower than the bony presenting part, so apparent station must be interpreted carefully.
Second-stage progress and wellbeing
Record when active pushing began and review descent and rotation as well as elapsed time. Reassess a nulliparous patient after an hour of pushing and a multiparous patient after thirty minutes. Lack of progress or emerging concern can require escalation before the usual senior-review time threshold.
Contractions, coping and reversible contributors
Assess contraction frequency and relaxation, bladder filling, analgesia and the patient's energy and wishes. External tocography does not reliably measure contraction strength. Provide support and appropriate hydration without assuming that larger fluid volumes will improve progress.
Red flags requiring action
Five or more contractions per ten minutes, or a sustained contraction with poor relaxation, requires reduction of uterine stimulation and reassessment.
A pathological CTG during oxytocin requires the infusion to stop and urgent obstetric review.
Investigations
01Repeat clinical examinationFirst step
Why
Confirm whether progress is genuinely delayed and identify likely mechanisms.
Interpretation and limitations
For suspected established first-stage delay, offer a vaginal examination two hours later and diagnose delay if dilatation has increased by less than 1 cm. Combine findings with abdominal palpation and the preceding course; consent and a clear reason remain necessary.
02Continuous cardiotocography
Why
Assess fetal response when oxytocin augmentation is used.
Interpretation and limitations
Review the baseline trace and current risk before starting, then monitor continuously during the infusion. An abnormal trace can reflect excessive activity or another complication. Stop oxytocin for a pathological trace and obtain assessment rather than simply reducing the monitoring interval.
03Ultrasound when position is uncertain
Why
Clarify fetal position when examination cannot establish it reliably.
Interpretation and limitations
Intrapartum ultrasound can assist assessment of position, particularly before an assisted birth decision. It supplements clinical judgement and operator expertise; it does not alone prove that vaginal birth will succeed or that augmentation is safe.
04Fluid balance and indicated blood tests
Why
Detect dehydration, infection or electrolyte disturbance during prolonged care.
Interpretation and limitations
Differential diagnosis
01
Physiological latent labour
An intermittent early phase can be lengthy without meeting criteria for established labour. Applying first-stage delay thresholds before the relevant stage creates unnecessary intervention and misleading expectations.
02
Unrecognised malpresentation
A presentation or position that was assumed earlier may need reconfirmation when progress is unusual. Examination and, when needed, ultrasound help identify the cause before stimulation is increased.
03
Evolving maternal or fetal complication
Infection, abruption or fetal compromise can accompany apparently slow labour. New symptoms or abnormal observations require their own assessment rather than attribution solely to exhaustion or dystocia.
Management
01Suspected first-stage delayConfirm the pattern before interventionFirst stepSerial assessment suggests slow progress in established first-stage labour.+
1Explain the findings, provide support and effective analgesia, and consider contractions, position, descent and maternal and fetal condition.
2Offer repeat examination after two hours; less than 1 cm further dilatation confirms delay in the NICE assessment sequence.
3If delay is confirmed and membranes are intact, consider amniotomy after discussing its effect on labour duration, contraction pain and relevant risks.
4Reassess two hours after amniotomy; no progress requires obstetric-led care and full assessment, including whether oxytocin is appropriate.
5EscalationEscalate immediately if maternal or fetal concerns develop, without waiting for the planned repeat examination.
Complications
01
Operative birth
Persisting delay or concern may require assisted vaginal birth or caesarean delivery. The choice depends on the stage, position, station, urgency and likelihood of a safe successful attempt.
02
Hyperstimulation and rupture
Excessive uterine activity can compromise the fetus and, particularly with an at-risk uterus, contribute to serious injury. Immediate reassessment is necessary when pain, bleeding or fetal abnormalities develop.
03
Fluid and postpartum problems
Prolonged treatment can contribute to exhaustion, fluid imbalance and postpartum bleeding risk. Monitoring should therefore continue beyond the cervical assessment and include recovery after birth.
Monitoring and follow-up
Document the infusion concentration, current dose, each increment and the associated contraction and CTG assessment so that handover preserves the treatment trajectory.
Review maternal pulse, blood pressure, temperature, symptoms and bladder function, increasing frequency when labour is prolonged or a new concern appears.
Track fluid balance during oxytocin because antidiuretic effects and excessive intake can produce dilutional hyponatraemia.
Record cervical change and fetal descent at the planned reassessment, and explain whether the findings support continuation or another route to birth.
After delivery, assess bleeding risk and provide an explanation of why augmentation or operative intervention was required.
Special situations
Stronger contractions can worsen the problem
If the head cannot descend because of an obstructed mechanical relationship, increasing uterine force does not address the cause. Rising moulding, absent descent and maternal or fetal deterioration should prompt a new birth plan.
The pump rate is not the drug dose
The same mL/hour rate delivers different oxytocin doses with different bag concentrations. Prescribe and communicate the pharmacological rate in milliunits/minute and verify the conversion during preparation, pump changes and transfer.
Amniotomy has a review point
Membrane rupture can intensify contractions but does not guarantee progress. The two-hour reassessment after amniotomy prevents an intervention from becoming an open-ended period without a documented response or next step.
A paused infusion needs reassessment
The uterus and fetus may respond differently after an interruption. NICE does not prescribe one universal restart dose; prior exposure, current contractions, trace findings and the reason for stopping should shape the decision.
Common pitfalls
01
Using a fixed one-centimetre-per-hour rule as the sole definition of abnormal labour.
02
Treating an unfavourable cervix before established labour as augmentation failure.
03
Increasing oxytocin more frequently than every thirty minutes to catch up with a timetable.
04
Restarting the previous infusion rate automatically after a pathological trace recovers.
05
Ignoring oral intake when investigating a large positive fluid balance.
06
Continuing augmentation despite evidence that the limiting problem is obstruction rather than contraction strength.
Persistent pain between contractions, fresh bleeding, maternal tachycardia or hypotension raises concern for rupture or another obstetric emergency.
No descent with increasing caput or moulding despite adequate contractions requires assessment for obstruction.
Headache, vomiting, confusion or seizures with a large positive fluid balance raises concern for hyponatraemia.
Record oral and intravenous intake and output when oxytocin or intravenous fluids are used. A positive balance of 1,500 mL or clinical symptoms should prompt obstetric review and sodium measurement under the NICE intrapartum pathway. Other tests depend on suspected infection, bleeding or maternal disease.
02AugmentationPrescribe and titrate oxytocin safelyObstetric assessment supports augmentation after confirmed delay and the patient agrees.+
1Review contraindications, uterine scar, fetal condition and previous uterotonic exposure, and ensure appropriate intravenous access and continuous CTG.
2Explain the expected stronger contractions and offer an epidural before starting or later if requested.
3Check the drug concentration, pump prescription and rate in milliunits per minute with the administration system before beginning the infusion.
4Increase no more frequently than every thirty minutes until three to four contractions occur in ten minutes; reduce or stop when contractions exceed four in ten minutes.
5After four hours of regular contractions produced by oxytocin, offer a vaginal examination; less than 2 cm dilatation requires further obstetric assessment of whether caesarean birth is advisable.
03Persistent or second-stage delayReassess the route to birthProgress remains inadequate despite treatment or delay occurs during active pushing.+
1Reassess fetal position, station, descent, contractions, analgesia and the patient's condition and preferences, excluding obstruction.
2Before any second-stage oxytocin, obtain in-person obstetric assessment confirming no obstruction, reassuring fetal wellbeing and infrequent or ineffective contractions.
3Seek senior review if birth is not imminent after two hours of active pushing in a nulliparous woman or one hour in a multiparous woman, with earlier review when progress is absent.
4If birth must be expedited, compare assisted vaginal birth with caesarean according to station, position, expected success, urgency and available expertise.
5If oxytocin was stopped for a pathological CTG, restart only after obstetric review, trace recovery and agreement; select the restart dose from the clinical assessment rather than automatically resuming the old maximum.
Key medicines and prescribing safety2 treatments · regimens, roles and cautions+
Strengthens uterine activity when ineffective contractions contribute to established delay.
Oxytocin infusion for labour augmentation
The cited UK SmPC starts at 1–4 milliunits/minute, with increments of 1–2 milliunits/minute. Apply the NICE interval of at least 30 minutes between increases, targeting 3–4 contractions per ten minutes. For near-term induction or enhancement, the cited SmPC recommends a maximum rate of 20 milliunits/minute.
Use a controlled intravenous infusion, never an augmentation bolus. A preparation of 5 units in 500 mL gives 10 milliunits/mL, so 1 milliunit/minute equals 6 mL/hour; other concentrations require recalculation. Stop for pathological CTG and review excessive activity, scar risk and fluid balance.
Relaxes the uterus when excessive contractions contribute to fetal compromise.
Terbutaline when augmentation causes excessive activity
Where acute tocolysis is indicated, NICE suggests terbutaline 0.25 mg by subcutaneous injection under obstetric supervision, with ongoing maternal and fetal monitoring after stopping oxytocin.
Assess cardiovascular and metabolic risks and the response to treatment. A uterine relaxant is not a solution to mechanical obstruction, rupture or persistent compromise requiring operative birth.